TWM
GILD icon

Thrive Wealth Management’s Gilead Sciences GILD Stock Holding History

Thrive Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,474
Closed -$205K – 264
2026
Q1 		$205K Buy
+1,474
New +$206K 0.03% 223
2024
Q4 		– Sell
-5,206
Closed -$437K – 210
2024
Q3 		$437K Sell
5,206
-1,788
-26% -$136K 0.08% 128
2024
Q2 		$480K Buy
6,994
+1,119
+19% +$74.7K 0.09% 107
2024
Q1 		$430K Sell
5,875
-1,900
-24% -$146K 0.09% 119
2023
Q4 		$630K Buy
7,775
+594
+8% +$46.2K 0.14% 91
2023
Q3 		$538K Buy
7,181
+157
+2% +$12.1K 0.14% 93
2023
Q2 		$541K Sell
7,024
-45
-0.6% -$3.59K 0.14% 92
2023
Q1 		$587K Buy
7,069
+883
+14% +$73.1K 0.15% 84
2022
Q4 		$531K Buy
6,186
+93
+2% +$7.37K 0.15% 86
2022
Q3 		$376K Buy
6,093
+1,301
+27% +$82K 0.13% 98
2022
Q2 		$296K Buy
+4,792
New +$297K 0.1% 122
2022
Q1 		– Sell
-4,907
Closed -$356K – 159
2021
Q4 		$356K Buy
+4,907
New +$338K 0.12% 109

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Thrive Wealth Management's GILD Position: Q2 2026 in Review

Thrive Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,474 shares — an estimated $205K sold.

Thrive Wealth Management first reported a position in GILD in Q4 2021 and held it in 12 quarters. The position peaked at $630K in Q4 2023. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Thrive Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Thrive Wealth Management sold 1,474 Gilead Sciences shares in Q2 2026, an estimated $205K.
  • Thrive Wealth Management first reported a position in Gilead Sciences in Q4 2021 and held it in 12 quarters.
  • Thrive Wealth Management's Gilead Sciences position peaked at $630K in Q4 2023.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.